David S. Ivill provides representation on regulatory and related transactional issues for a wide array of health industry clients, including for-profit and nonprofit hospitals, covered entities involved in the 340B Federal Drug Pricing Program, private equity firms, post-acute providers, large medical group providers and specialty pharmacies. He provides operational and management advice in the context of complex regulatory frameworks, whether it be for the course of business or in connection with affiliations or mergers and acquisitions. He has extensive experience in statutory and regulatory issues affecting the provision of health care services, particularly with respect to New York State. David is the partner-in-charge of the Health Industry Advisory Practice in New York.

Show More


  • The Legal 500 US 2016
  • The Best Lawyers in America 2011 to 2019
  • Chambers USA 2015 to 2019


New York University School of Law, JD
Pennsylvania College of Podiatric Medicine, DPM
Westminster College, BS, cum laude

New York

David S. Ivill

Insights & Events / Media

Berlin, Germany / McDermott Event / February 27, 2019

San Francisco, California / McDermott Event / January 10, 2017

On the Subject / August 31, 2015